2,148
Views
43
CrossRef citations to date
0
Altmetric
Reviews

Evolving trends in next-generation probiotics: a 5W1H perspective

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Anhê, F. F., G. Pilon, D. Roy, Y. Desjardins, E. Levy, and A. Marette. 2016. Triggering akkermansia with dietary polyphenols: A new weapon to combat the metabolic syndrome? Gut Microbes. 7 (2):146–53.
  • Axelrad, J.E., O. Olén, J. Askling, B. Lebwohl, H. Khalili, M. C. Sachs, and J. F. Ludvigsson. 2018. Gastrointestinal Infection Increases odds of inflammatory bowel disease in a nationwide case-control study. Clinical Gastroenterology and Hepatology. pii: S1542-3565(18)31025–5.
  • Belenguer, A., S. H. Duncan, A. G. Calder, G. Holtrop, P. Louis, G. E. Lobley, and H. J. Flint. 2006. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Applied and Environmental Microbiology 72 (5):3593–9.
  • Belzer, C., L. W. Chia, S. Aalvink, B. Chamlagain, V. Piironen, J. Knol, and W. M. de Vos. 2017. Microbial metabolic networks at the mucus layer lead to diet-independent butyrate and vitamin B 12 production by intestinal symbionts. mBio 8 (5):e00770–17.
  • Blaser, M. J., and S. Falkow. 2009. What are the consequences of the disappearing human microbiota? Nature Reviews Microbiology 7 (12):887–94.
  • Bordoni, A., F. Danesi, D. Dardevet, D. Dupont, A. S. Fernandez, D. Gille, C. Nunes dos Santos, P. Pinto, R. Re, D. Rémond, et al. 2017. Dairy products and inflammation: A review of the clinical evidence. Critical Reviews in Food Science and Nutrition 57 (12):2497–525.
  • Breyner, N. M., C. Michon, C. S. de Sousa, P. B. Vilas Boas, F. Chain, V. A. Azevedo, P. Langella, and J. M. Chatel. 2017. Microbial anti-Inflammatory molecule (MAM) from Faecalibacterium prausnitzii shows a protective effect on DNBS and DSS-Induced colitis model in mice through inhibition of NF-κB pathway. Frontiers in Microbiology 8:114.
  • Brodmann, T., A. Endo, M. Gueimonde, G. Vinderola, W. Kneifel, W. M. de Vos, S. Salminen, and C. Gómez-Gallego. 2017. Safety of novel microbes for human consumption: Practical examples of assessment in the European Union. Frontiers in Microbiology 8:1725.
  • Brooks, C., N. Pearce, and J. Douwes. 2013. The hygiene hypothesis in allergy and asthma. Current Opinion in Allergy and Clinical Immunology 13 (1):70–7.
  • Candela, M., S. Rampelli, S. Turroni, M. Severgnini, C. Consolandi, G. De Bellis, R. Masetti, G. Ricci, A. Pession, P. Brigidi, et al. 2012. Unbalance of intestinal microbiota in atopic children. BMC Microbiology 12 (1):95.
  • Cani, P. D. 2017. Gut microbiota — At the intersection of everything? Nature Reviews Gastroenterology & Hepatology 14 (6):321–2.
  • Cani, P. D. 2018. Human gut microbiome: Hopes, threats and promises. Gut 67 (9):1716–25.
  • Cani, P. D., and A. Everard. 2014. Akkermansia muciniphila: A novel target controlling obesity, type 2 diabetes and inflammation? Medecine sciences (Paris) 30 (2):125–7.
  • Cani, P. D., and M. Van Hul. 2015. Novel opportunities for next-generation probiotics targeting metabolic syndrome. Current Opinion in Biotechnology 32:21–7.
  • Carlsson, A. H., O. Yakymenko, I. Olivier, F. Håkansson, E. Postma, Å. V. Keita, and J. D. Söderholm. 2013. Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scandinavian Journal of Gastroenterology 48 (10):1136–44.
  • Celiberto, L. S., R. Bedani, E. A. Rossi, and D. C. Cavallini. 2015. Probiotics: The scientific evidence in the context of inflammatory bowel disease. Critical Reviews in Food Science and Nutrition 57 (9):1759–68.
  • Cordain, L., S. B. Eaton, A. Sebastian, N. Mann, S. Lindeberg, B. A. Watkins, J. H. O'Keefe, and J. Brand-Miller. 2005. Origins and evolution of the Western diet: Health implications for the 21st century. The American Journal of Clinical Nutrition 81 (2):341–54.
  • Cui, X., L. Ye, J. Li, L. Jin, W. Wang, S. Li, M. Bao, S. Wu, L. Li, B. Geng, et al. 2018. Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients. Scientific Reports 8 (1):635.
  • D’Argenio, V., and F. Salvatore. 2015. The role of the gut microbiome in the healthy adult status. Clinica Chimica Acta: International Journal of Clinical Chemistry 451 (Pt A):97–102.
  • Dao, M. C., A. Everard, J. Aron-Wisnewsky, N. Sokolovska, E. Prifti, E. O. Verger, B. D. Kayser, F. Levenez, J. Chilloux, L. Hoyles, et al. 2016. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology. Gut 65 (3):426–36.
  • Degnan, P. H., M. E. Taga, and A. L. Goodman. 2014. Vitamin B12 as a modulator of gut microbial ecology. Cell Metabolism 20 (5):769–78.
  • Derrien, M., E. E. Vaughan, C. M. Plugge, and W. M. de Vos. 2004. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. International Journal of Systematic and Evolutionary Microbiology 54 (5):1469–76.
  • Derrien, M., C. Belzer, and W. M. de Vos. 2017. Akkermansia muciniphila and its role in regulating host functions. Microbial Pathogenesis 106:171–81.
  • Dolan, G. P., K. Foster, J. Lawler, C. Amar, C. Swift, H. Aird, and R. Gorton. 2016. An epidemiological review of gastrointestinal outbreaks associated with Clostridium perfringens, North East of England, 2012–2014. Epidemiology and Infection 144 (07):1386–93.
  • Douillard, F. P., and W. M. de Vos. 2014. Functional genomics of lactic acid bacteria: from food to health. Microbial Cell Factories 13 (Suppl 1):S8.
  • Duncan, S. H., P. Louis, and H. J. Flint. 2004. Lactate-Utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Applied and Environmental Microbiology 70 (10):5810–7.
  • El Hage, R., E. Hernandez-Sanabria, and T. Van de Wiele. 2017. Emerging trends in “smart probiotics”: functional consideration for the development of novel health and industrial applications. Frontiers in Microbiology 8:1889.
  • Engels, C., H. J. Ruscheweyh, N. Beerenwinkel, C. Lacroix, and C. Schwab. 2016. The common gut microbe Eubacterium hallii also contributes to intestinal propionate formation. Frontiers in Microbiology 7:713.
  • European Commission. 2015. European commission (2015). R. E. 2015/2283. Regulation (EU) 2015/2283 of the European parliament and of the council of 25 November 2015 on novel foods, Amending Regulation (EU), No 1169/2011 of the European Parliament and of the Council and Repealing Regu, European Union: FAO, FAOLEX. eur-lex.europa.eu.
  • Everard, A., C. Belzer, L. Geurts, J. P. Ouwerkerk, C. Druart, L. B. Bindels, Y. Guiot, M. Derrien, G. G. Muccioli, N. M. Delzenne, et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences 110 (22):9066–71.
  • Everard, A., V. Lazarevic, M. Derrien, M. Girard, G. G. Muccioli, A. M. Neyrinck, S. Possemiers, A. Van Holle, P. François, W. M. de Vos, et al. 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60 (11):2775–86.
  • Fekry, M. I., C. Engels, J. Zhang, C. Schwab, C. Lacroix, S. J. Sturla, and C. Chassard. 2016. The strict anaerobic gut microbe Eubacterium hallii transforms the carcinogenic dietary heterocyclic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Environmental Microbiology Reports 8 (2):201–9.
  • Fisher, C. K., and P. Mehta. 2014. Identifying Keystone Species in the Human Gut Microbiome from Metagenomic Timeseries Using Sparse Linear Regression. PLoS ONE 9 (7):e102451. http://dx.plos.org/10.1371/journal.pone.0102451.
  • Foditsch, C., T. M. Santos, A. G. Teixeira, R. V. Pereira, J. M. Dias, N. Gaeta, and R. C. Bicalho. 2014. Isolation and characterization of Faecalibacterium prausnitzii from calves and piglets. PLoS ONE 9 (12):e116465.
  • Foditsch, C., R. V. Pereira, E. K. Ganda, M. S. Gomez, E. C. Marques, T. Santin, R. C. Bicalho et al. 2015. Oral administration of Faecalibacterium prausnitzii decreased the incidence of severe diarrhea and related mortality rate and increased weight gain in preweaned dairy heifers. Plos one 10(12):e0145485.
  • Gänzle, M. G. 2015. Lactic metabolism revisited: metabolism of lactic acid bacteria in food fermentations and food spoilage. Current Opinion in Food Science 2(2):106–17.
  • Garcia-Mantrana, I., M. Selma-Royo, C. Alcantara, and M. C. Collado. 2018. Shifts on gut microbiota associated to Mediterranean diet adherence and specific dietary intakes on general adult population. Frontiers in Microbiology 9:890.
  • GBD 2015 Obesity Collaborators, A. Afshin, M. H. Forouzanfar, M. B. Reitsma, P. Sur, K. Estep, A. Lee, L. Marczak, A. H. Mokdad, M. Moradi-Lakeh, et al. 2017. Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine 377 (1):13–27.
  • Gomes, A.M., J. Andrade, and A. Freitas. 2017. The use of probiotics in the food industry. In Strategies for obtaining healthier foods, eds. J. M. Lorenzo Rodríguez and F. J. Carballo García, 129–182. New York: Food Science and Technology, Nova Science Publishers Inc.
  • Greer, R. L., X. Dong, A. C. Moraes, R. A. Zielke, G. R. Fernandes, E. Peremyslova, S. Vasquez-Perez, A. A. Schoenborn, E. P. Gomes, A. C. Pereira et al. 2016. Akkermansia muciniphila mediates negative effects of IFNγ on glucose metabolism. Nature Communications 7:13329.
  • Hartstra, A. V., K. E. C. Bouter, F. Bäckhed, and M. Nieuwdorp. 2015. Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care 38 (1):159–65.
  • Heinken, A., M. T. Khan, G. Paglia, D. A. Rodionov, H. J. M. Harmsen, and I. Thiele. 2014. Functional metabolic map of Faecalibacterium prausnitzii, a beneficial human gut microbe. Journal of Bacteriology 196 (18):3289–302.
  • Hill, C., F. Guarner, G. Reid, G. R. Gibson, D. J. Merenstein, B. Pot, L. Morelli, R. B. Canani, H. J. Flint, S. Salminen, et al. 2014. Expert consensus document: The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11 (8):506–14.
  • Jeffery, I. B., D. B. Lynch, and P. W. O'Toole. 2016. Composition and temporal stability of the gut microbiota in older persons. The ISME Journal 10 (1):170–82.
  • Jordán, F., M. Lauria, M. Scotti, T.-P. Nguyen, P. Praveen, M. Morine, and C. Priami. 2015. Diversity of key players in the microbial ecosystems of the human body. Scientific Reports 5:15920
  • Kang, C.-s., M. Ban, E.-J. Choi, H.-G. Moon, J.-S. Jeon, D.-K. Kim, S.-K. Park, S. G. Jeon, T.-Y. Roh, S.-J. Myung. et al. 2013. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate Sodium-Induced colitis. Plos One 8 (10):e76520.
  • Khan, M. T., S. H. Duncan, A. J. M. Stams, J. M. van Dijl, H. J. Flint, and H. J. M. Harmsen. 2012. The gut anaerobe Faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic–anoxic interphases. The ISME Journal 6 (8):1578–85.
  • Khan, M. T., J. M. van Dijl, and H. J. M. Harmsen. 2014. Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air. PLoS ONE 9 (5):e96097–4.
  • Krebs-Smith, S. M., P. M. Guenther, A. F. Subar, S. I. Kirkpatrick, and K. W. Dodd. 2010. Americans do not meet federal dietary recommendations. The Journal of Nutrition 140 (10):1832–8.
  • Laforest-Lapointe, I., and M.-C. Arrieta. 2017. Patterns of early-life gut microbial colonization during human immune development: An ecological perspective. Frontiers in immunology 8:788.
  • Li, J., S. Lin, P. M. Vanhoutte, C. W. Woo, and A. Xu. 2016. Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in apoe −/− mice. Clinical Perspective: Circulation 133 (24):2434–46.
  • Lopez-Siles, M., T. M. Khan, S. H. Duncan, H. J. M. Harmsen, L. J. Garcia-Gil, and H. J. Flint. 2012. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Applied and Environmental Microbiology 78 (2):420–8.
  • Lopez-Siles, M., S. H. Duncan, L. J. Garcia-Gil, and M. Martinez-Medina. 2017. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. The ISME Journal 11 (4):841–52.
  • Louis, P., P. Young, G. Holtrop, and H. J. Flint. 2010. Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl-CoA:acetate CoA-transferase gene. Environmental Microbiology 12 (2):304–14.
  • Marchesi, J. R., D. H. Adams, F. Fava, G. D. A. Hermes, G. M. Hirschfield, G. Hold, M. N. Quraishi, J. Kinross, H. Smidt, K. M. Tuohy, et al. 2016. The gut microbiota and host health: A new clinical frontier. Gut 65 (2):330–9.
  • Martín, R., S. Miquel, F. Chain, J. M. Natividad, J. Jury, J. Lu, H. Sokol, V. Theodorou, P. Bercik, E. F. Verdu, et al. 2015. Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiology 15:67.
  • Martín, R., S. Miquel, L. Benevides, C. Bridonneau, V. Robert, S. Hudault, F. Chain, O. Berteau, V. Azevedo, J. M. Chatel, et al. 2017. Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy volunteers: A step forward in the use of F. prausnitzii as a Next-Generation probiotic. Frontiers in Microbiology 8:1226.
  • Martín, R., F. Chain, S. Miquel, J. Lu, J.-J. Gratadoux, H. Sokol, E. F. Verdu, P. Bercik, L. G. Bermúdez-Humarán, P. Langella, et al. 2014. The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflammatory Bowel Diseases 20 (3):417–30.
  • Masuko, K. 2018. A potential benefit of “Balanced Diet for Rheumatoid Arthritis”. Frontiers in Medicine 5:141.
  • Metchnikoff, E. 1908. The prolongation of life: Optimistic studies. New York: Putnam’s Sons.
  • Miquel, S., R. Martín, A. Lashermes, M. Gillet, M. Meleine, A. Gelot, A. Eschalier, D. Ardid, L. G. Bermúdez-Humarán, H. Sokol, et al. 2016. Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models. Scientific Reports 6:19399.
  • Miquel, S., R. Martín, O. Rossi, L. G. Bermúdez-Humarán, J. M. Chatel, H. Sokol, M. Thomas, J. M. Wells, and P. Langella. 2013. Faecalibacterium prausnitzii and human intestinal health. Current Opinion in Microbiology 16 (3):255–61.
  • Miquel, S., M. Leclerc, R. Martin, F. Chain, M. Lenoir, S. Raguideau, S. Hudault, C. Bridonneau, T. Northen, B. Bowen, et al. 2015. Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii. mBio 6 (2):e00300-15.
  • Moens, F., S. Weckx, and L. De Vuyst. 2016. Bifidobacterial inulin-type fructan degradation capacity determines cross-feeding interactions between bifidobacteria and Faecalibacterium prausnitzii. International Journal of Food Microbiology 231:76–85.
  • Munukka, E., A. Rintala, R. Toivonen, M. Nylund, B. Yang, A. Takanen, A. Hänninen, J. Vuopio, P. Huovinen, S. Jalkanen, et al. 2017. Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice. The ISME Journal 11 (7):1667–79.
  • Neef, A., and Y. Sanz. 2013. Future for probiotic science in functional food and dietary supplement development. Current Opinion in Clinical Nutrition and Metabolic Care 16 (6):679–87.
  • Nguyen, H.-T., D.-H. Truong, S. Kouhoundé, S. Ly, H. Razafindralambo, and F. Delvigne. 2016. Biochemical engineering approaches for increasing viability and functionality of probiotic bacteria. International Journal of Molecular Sciences 17 (6):867.
  • O’Toole, P. W., J. R. Marchesi, and C. Hill. 2017. Next-generation probiotics: The spectrum from probiotics to live biotherapeutics. Nature Microbiology 2 (5):17057.
  • O’Toole, P. W., and M. Paoli. 2017. The contribution of microbial biotechnology to sustainable development goals: Microbiome therapies. Microbial Biotechnology 10 (5):1066–9.
  • Ottman, N., J. Reunanen, M. Meijerink, T. E. Pietilä, V. Kainulainen, J. Klievink, L. Huuskonen, S. Aalvink, M. Skurnik, S. Boeren, et al. 2017. Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function. Plos ONE 12 (3):e0173004.
  • Ottman, N., H. Smidt, W. M. de Vos, and C. Belzer. 2012. The function of our microbiota: who is out there and what do they do? Frontiers in Cellular and Infection Microbiology 2:104
  • Ouwerkerk, J. P., K. C. H. van der Ark, M. Davids, N. J. Claassens, T. R. Finestra, W. M. de Vos, and C. Belzer. 2016. Adaptation of Akkermansia muciniphila to the oxic-anoxic interface of the mucus layer. Applied and Environmental Microbiology 82 (23):6983–93.
  • Ouwerkerk, J. P., S. Aalvink, C. Belzer, and W. M. De Vos. 2017. Preparation and preservation of viable Akkermansia muciniphila cells for therapeutic interventions. Beneficial Microbes 8 (2):163–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/28116930 [Accessed August 2, 2018]. doi: 10.3920/BM2016.0096.
  • Paine, R. T. 1969. A note on trophic complexity and community stability. The American Naturalist 103 (929):91–3.
  • Patel, R., and H. L. DuPont. 2015. New approaches for bacteriotherapy: Prebiotics, new-generation probiotics, and synbiotics. Clinical Infectious Diseases 60 (suppl_2):S108–S21. doi: 10.1093/cid/civ177.
  • Plaza-Díaz, J., F. Ruiz-Ojeda, L. Vilchez-Padial, and A. Gil. 2017. Evidence of the anti-inflammatory effects of probiotics and synbiotics in intestinal chronic diseases. Nutrients 9 (6):555.
  • Plovier, H., A. Everard, C. Druart, C. Depommier, M. Van Hul, L. Geurts, J. Chilloux, N. Ottman, T. Duparc, L. Lichtenstein, et al. 2016. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nature Medicine 23 (1):107–13.
  • Png, C. W., S. K. Lindén, K. S. Gilshenan, E. G. Zoetendal, C. S. McSweeney, L. I. Sly, M. A. McGuckin, and T. H. J. Florin. 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. The American Journal of Gastroenterology 105 (11):2420–8.
  • Quercia, S., M. Candela, C. Giuliani, S. Turroni, D. Luiselli, S. Rampelli, P. Brigidi, C. Franceschi, M. G. Bacalini, P. Garagnani, C. Pirazzini, et al. 2014. From lifetime to evolution: Timescales of human gut microbiota adaptation. Frontiers in Microbiology 5:587.
  • Quévrain, E., M. A. Maubert, C. Michon, F. Chain, R. Marquant, J. Tailhades, S. Miquel, L. Carlier, L. G. Bermúdez-Humarán, B. Pigneur, et al. 2016. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in crohn’s disease. Gut 65 (3):415–25.
  • Rajilić-Stojanović, M., E. Biagi, H. G. Heilig, K. Kajander, R. A. Kekkonen, S. Tims, W. M. de Vos. 2011. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141 (5):1792–801.
  • Reichardt, N., S. H. Duncan, P. Young, A. Belenguer, C. McWilliam Leitch, K. P. Scott, H. J. Flint, and P. Louis. 2014. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. The ISME Journal 8 (6):1323–35.
  • Reigstad, C. S., C. E. Salmonson, J. F. Rainey, J. H. Szurszewski, D. R. Linden, J. L. Sonnenburg, G. Farrugia, and P. C. Kashyap. 2015. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. The FASEB Journal 29 (4):1395–403.
  • Reunanen, J., V. Kainulainen, L. Huuskonen, N. Ottman, C. Belzer, H. Huhtinen, W. M. de Vos, and R. Satokari. 2015. Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell. Applied and Environmental Microbiology 81 (11):3655–3662.
  • Rios-Covian, D., M. Gueimonde, S. H. Duncan, H. J. Flint, and C. G. de los Reyes-Gavilan. 2015. Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiology Letters 362 (21):fnv176.
  • Rossi, O., L. A. van Berkel, F. Chain, M. T. Khan, N. Taverne, H. Sokol, S. H. Duncan, H. J. Flint, H. J. M. Harmsen, P. Langella, J. N. Samsom, and J. M. Wells. 2016. Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses. Scientific Reports 6:18507.
  • Rossi, O., M. T. Khan, M. Schwarzer, T. Hudcovic, D. Srutkova, S. H. Duncan, E. H. Stolte, H. Kozakova, H. J. Flint, J. N. Samsom, et al. 2015. Faecalibacterium prausnitzii strain HTF-F and its extracellular polymeric matrix attenuate clinical parameters in DSS-Induced colitis. PloS One 10 (4):e0123013.
  • Saarela, M. H. 2018. Safety aspects of next generation probiotics. Current Opinion in Food Science 30:8–13.
  • Sadaghian Sadabad, M., J. Z. H. von Martels, M. T. Khan, T. Blokzijl, G. Paglia, G. Dijkstra, H. J. M. Harmsen, and K. N. Faber. 2016. A simple coculture system shows mutualism between anaerobic faecalibacteria and epithelial caco-2 cells. Scientific Reports 5 (1):17906.
  • Sarrabayrouse, G., J. Alameddine, F. Altare, and F. Jotereau. 2015. Microbiota-Specific CD4CD8αα tregs: Role in intestinal immune homeostasis and implications for IBD. Frontiers in Immunology 6:522.
  • Schneeberger, M., A. Everard, A. G. Gómez-Valadés, S. Matamoros, S. Ramírez, N. M. Delzenne, R. Gomis, M. Claret, and P. D. Cani. 2015. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Scientific Reports 5 (1):16643.
  • Schwab, C., H. J. Ruscheweyh, V. Bunesova, V. T. Pham, N. Beerenwinkel, and C. Lacroix. 2017. Trophic interactions of infant bifidobacteria and Eubacterium hallii during L-Fucose and fucosyllactose degradation. Frontiers in Microbiology 8:95.
  • Shetty, S. A., F. Hugenholtz, L. Lahti, H. Smidt, and W. M. de Vos. 2017. Intestinal microbiome landscaping: Insight in community assemblage and implications for microbial modulation strategies. FEMS Microbiology Reviews 41 (2):182–99.
  • Silva, J.P.S., Freitas, and A.C. Freitas. 2014. Probiotic bacteria, ed. A. Freitas. New York: Pan Stanford Publishing.
  • Sokol, H., B. Pigneur, L. Watterlot, O. Lakhdari, L. G. Bermudez-Humaran, J.-J. Gratadoux, S. Blugeon, C. Bridonneau, J.-P. Furet, G. Corthier, et al. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of crohn disease patients. Proceedings of the National Academy of Sciences 105 (43):16731–6.
  • Song, H., Y. Yoo, J. Hwang, Y.-C. Na, and H. S. Kim. 2016. Faecalibacterium prausnitzii subspecies–level dysbiosis in the human gut microbiome underlying atopic dermatitis. Journal of Allergy and Clinical Immunology 137 (3):852–60.
  • Sonoyama, K., T. Ogasawara, H. Goto, T. Yoshida, N. Takemura, R. Fujiwara, J. Watanabe, H. Ito, T. Morita, Y. Tokunaga, et al. 2010. Comparison of gut microbiota and allergic reactions in BALB/c mice fed different cultivars of rice. British Journal of Nutrition 103 (02):218.
  • Sousa, S., A. M. Gomes, M. M. Pintado, J. P. Silva, P. Costa, M. H. Amaral, A. C. Duarte, D. Rodrigues, T. A. P. Rocha-Santos, A. C. Freitas, et al. 2015. Characterization of freezing effect upon stability of, probiotic loaded, calcium-alginate microparticles. Food and Bioproducts Processing 93:90–7.
  • Sousa, S., A. M. Gomes, M. M. Pintado, F. X. Malcata, J. P. Silva, J. M. Sousa, P. Costa, M. H. Amaral, D. Rodrigues, T. A. P. Rocha-Santos. et al. 2012. Encapsulation of probiotic strains in plain or cysteine-supplemented alginate improves viability at storage below freezing temperatures. Engineering in Life Sciences 12 (4):457–65.
  • Stewart, C. S., G. L. Hold, H. J. Harmsen, C. S. Stewart, and H. J. Flint. 2002. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. International Journal of Systematic and Evolutionary Microbiology 52 (6):2141–6.
  • Tan, L., S. Zhao, W. Zhu, L. Wu, J. Li, M. X. Shen, L. Lei, X. Chen, and C. Peng. 2018. The Akkermansia muciniphila is a gut microbiota signature in psoriasis. Experimental Dermatology 27 (2):144–9.
  • Tap, J., S. Mondot, F. Levenez, E. Pelletier, C. Caron, J.-P. Furet, E. Ugarte, R. Muñoz-Tamayo, D. L. E. Paslier, R. Nalin, et al. 2009. Towards the human intestinal microbiota phylogenetic core. Environmental Microbiology 11 (10):2574–84.
  • Trosvik, P., and E. J. de Muinck. 2015. Ecology of bacteria in the human gastrointestinal tract–identification of keystone and foundation taxa. Microbiome 3:44.
  • Udayappan, S., L. Manneras-Holm, A. Chaplin-Scott, C. Belzer, H. Herrema, G. M. Dallinga-Thie, S. H. Duncan, E. S. G. Stroes, A. K. Groen, H. J. Flint et al. 2016. Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice. Npj Biofilms and Microbiomes 2 (1):16009.
  • Ulluwishewa, D., R. C. Anderson, W. Young, W. C. McNabb, P. van Baarlen, P. J. Moughan, J. M. Wells, and N. C. Roy. 2015. Live Faecalibacterium prausnitzii in an apical anaerobic model of the intestinal epithelial barrier. Cellular Microbiology 17 (2):226–40.
  • van der Ark, K. C. H., A. D. W. Nugroho, C. Berton-Carabin, C. Wang, C. Belzer, W. M. de Vos, and K. Schroen. 2017. Encapsulation of the therapeutic microbe Akkermansia muciniphila in a double emulsion enhances survival in simulated gastric conditions. Food Research International 102:372–9.
  • Vanhaecke, L., M. G. Knize, H. Noppe, H. De Brabander, W. Verstraete, and T. Van de Wiele. 2008. Intestinal bacteria metabolize the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans. Food and Chemical Toxicology 46 (1):140–8.
  • Walker, A.W., J. Ince, S. H. Duncan, L. M. Webster, G. Holtrop, X. Ze, D. Brown, M. D. Stares, P. Scott, A. Bergerat, et al. 2011. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. The ISME Journal 5 (2):220–30.
  • Wu, W., L. Lv, D. Shi, J. Ye, D. Fang, F. Guo, Y. Li, X. He, and L. Li. 2017. Protective effect of Akkermansia muciniphila against immune-mediated liver injury in a mouse model. Frontiers in Microbiology 8:1804.
  • Yano, J. M., K. Yu, G. P. Donaldson, G. G. Shastri, P. Ann, L. Ma, C. R. Nagler, R. F. Ismagilov, S. K. Mazmanian, E. Y. Hsiao, et al. 2015. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161 (2):264–76.
  • Zhang, X., D. Shen, Z. Fang, Z. Jie, X. Qiu, C. Zhang, Y. Chen, and L. Ji. 2013. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS ONE 8(8):e71108.
  • Zheng, H., H. Liang, Y. Wang, M. Miao, T. Shi, F. Yang, E. Liu, W. Yuan, Z.-S. Ji, D.-K. Li, et al. 2016. Altered gut microbiota composition associated with eczema in infants. Plos ONE 11 (11):e0166026.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.